🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cushing Disease

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion NCT07361874NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Intervention 1: Adrenalectomy, Intervention 2: Semaglutide Collecting Information About Treatment Results for Patients With Cushing's Syndrome NCT03364803n/a7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cushing's QoL (Quality of Life Questionnaire), Nottingham Health Profile (NHP), Hospital Anxiety and Depression Sc… Adrenal Tumors - Pathogenesis and Therapy NCT00669266n/a1 site📍 Würzburg University of Wuerzburg Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders NCT04374721NA1 site📍 Roma University of Roma La Sapienza · Tests: circadian gene expression evaluation Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome NCT02019706Phase 21 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… · Tests: DOTATATE PET-CT, F-DOPA PET CT, CT scan, Routine MRI scan, Gated MRI scan NAC- NAFLD And Cushing NCT05881005NA7 sites📍 Angers📍 Bordeaux📍 Brest University Hospital, Angers · Tests: hepatic MRI FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease NCT07460232EARLY Phase 11 site📍 Rochester Mayo Clinic · Tests: Fluoro-O-(2) fluoroethyl-L-tyrosine (FET) PET Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome NCT03708900Phase 215 sites📍 San Francisco📍 Cape Coral📍 Chicago RECORDATI GROUP · Tests: LCI699 Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's Syndrome NCT07350707Phase 1, Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: 68Ga-Pentixafor Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT NCT06962202n/a1 site📍 Chandigarh Post Graduate Institute of Medical Education and Research, … Study of the Steroid Hormone Milieu in Obese Patients NCT06341699n/a1 site📍 Oggebbio Istituto Auxologico Italiano Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS) NCT04543253n/a1 site📍 Rochester Mayo Clinic · Tests: MUSE biofeedback Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. NCT07463625n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Data-only evaluation of [18F]FET PET, pituitary MRI, and biomarkers Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease NCT05971758Phase 21 site📍 Los Angeles University of California, Los Angeles · Tests: Fimepinostat Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome NCT06801249Phase 43 sites📍 Bologna📍 Naples📍 Padova IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Metarapone, Standardized antihypertensive therapy A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement NCT06430528n/a1 site📍 Ann Arbor University of Michigan · Tests: Osilodrostat Impact of Adrenal IncidenTalomas and Possible Autonomous Cortisol Secretion on Cardiovascular and Metabolic Alterations NCT04127552n/a1 site📍 Rome University of Roma La Sapienza · Tests: Adrenalectomy Cushing's Syndrome Before and After Treatment (CORRECT) NCT05521529n/a1 site📍 Aarhus University of Aarhus · Tests: no intervention, as this is an observational study Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) NCT07247058Phase 41 site📍 Baltimore Johns Hopkins University · Tests: Osilodrostat (Isturisa) DDAVP for Pituitary Adenoma NCT04569591NA1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: Desmopressin acetate Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism NCT05368090NA1 site📍 Bergen Haukeland University Hospital · Tests: EUS-RFA of left adrenal tumour in PA with AVS-verified left lateralisation, EUS-RFA of left adrenal tumour in PA, "… Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism NCT06246357Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: [68Ga]Ga-PentixaFor A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery NCT06250699NA1 site📍 Wuhan Zhe Meng · Tests: Tubeless laparoscopic adrenalectomy, Drainage tube Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors NCT07335315n/a1 site📍 Rochester Mayo Clinic · Tests: Contrast enhanced pituitary magnetic resonance imaging (MRI), Contrast enhanced ultrasound, Non-Contrast Ultrasound Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases NCT07703683n/a1 site📍 Woluwe-Saint-Pierre - Sint-Pieters-Woluwe Cliniques universitaires Saint-Luc- Université Catholique d… · Tests: GLP-1 Receptor Agonists An Investigation of Pituitary Tumors and Related Hypothalmic Disorders NCT00001595n/a1 site📍 Bethesda Eunice Kennedy Shriver National Institute of Child Health a… · Tests: Tissue specimen collection, MRI Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome NCT06635629Phase 21 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… · Tests: Desmopressin, Dexamethasone Establishment and Clinical Application of Reference Intervals of Salivary Cortisol NCT07168122n/a1 site📍 Shanghai Shanghai 6th People's Hospital REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) NCT07412782NA1 site📍 Florence Meyer Children's Hospital IRCCS · Tests: REMS Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) NCT07104812Phase 21 site📍 Rochester Mayo Clinic · Tests: Osilodrostat 1 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy